|
OMIM |
Link |
Information gain |
01 |
|
twinning, dizygotic
|
[NCBI]
|
0.00830336
|
|
|
autism
|
[NCBI]
|
0.00229638
|
|
|
MENOQ1
|
[NCBI]
|
0.00119001
|
|
|
ANON1
|
[NCBI]
|
0.00113159
|
|
|
theophylline biotransformation
|
[NCBI]
|
0.000990729
|
|
|
mammographic density
|
[NCBI]
|
0.000990729
|
|
|
bone size quantitative trait locus 1
|
[NCBI]
|
0.000627545
|
|
|
renal-hepatic-pancreatic dysplasia with dandy-walker cyst
|
[NCBI]
|
0.000627545
|
|
|
tune deafness
|
[NCBI]
|
0.000627545
|
|
|
astigmatism
|
[NCBI]
|
0.000627545
|
|
|
DYX6
|
[NCBI]
|
0.000563606
|
|
|
MAFD2
|
[NCBI]
|
0.000553856
|
|
|
jejunal atresia
|
[NCBI]
|
0.000478883
|
|
|
MNG1
|
[NCBI]
|
0.000447918
|
|
|
centralopathic epilepsy
|
[NCBI]
|
0.000378425
|
|
|
BULN1
|
[NCBI]
|
0.000378425
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
0.000343986
|
|
|
PAND1
|
[NCBI]
|
0.000302828
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000302828
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.000260489
|
|
|
RA
|
[NCBI]
|
0.000254008
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
0.000244495
|
|
|
holoprosencephaly
|
[NCBI]
|
0.000188521
|
|
|
DYX1
|
[NCBI]
|
0.000185543
|
|
|
DWS
|
[NCBI]
|
0.000182996
|
|
|
PCD
|
[NCBI]
|
0.000182996
|
|
|
twinning, monozygotic
|
[NCBI]
|
0.000163424
|
|
|
MS
|
[NCBI]
|
0.000154187
|
|
|
PCOS1
|
[NCBI]
|
0.000149771
|
|
|
GBD1
|
[NCBI]
|
0.000147199
|
|
|
BMND1
|
[NCBI]
|
0.000135761
|
|
|
HMS1
|
[NCBI]
|
0.000129655
|
|
|
FSHR
|
[NCBI]
|
0.000127701
|
|
|
DYX2
|
[NCBI]
|
0.00012438
|
|
|
nasal alar collapse, bilateral
|
[NCBI]
|
0.000123493
|
|
|
ureterocele
|
[NCBI]
|
0.000123493
|
|
|
folate level in erythrocytes
|
[NCBI]
|
0.000123493
|
|
|
lip prints
|
[NCBI]
|
0.000123493
|
|
|
twinning due to superfetation
|
[NCBI]
|
0.000123493
|
|
|
jejunal atresia with renal adysplasia
|
[NCBI]
|
0.000123493
|
|
|
PPAB
|
[NCBI]
|
0.000123493
|
|
|
breast cancer
|
[NCBI]
|
0.000123089
|
|
|
ETM1
|
[NCBI]
|
0.000115597
|
|
|
CPI
|
[NCBI]
|
0.000112999
|
|
|
osteoporosis
|
[NCBI]
|
0.000110118
|
|
|
ADHD
|
[NCBI]
|
0.000105526
|
|
|
OFC1
|
[NCBI]
|
9.74242e-05
|
|
|
lithium transport
|
[NCBI]
|
9.57611e-05
|
|
|
acne, adult
|
[NCBI]
|
9.57611e-05
|
|
|
langerhans cell histiocytosis
|
[NCBI]
|
9.57611e-05
|
|
|
periodontitis, chronic
|
[NCBI]
|
9.57611e-05
|
|
|
craniostenosis, sagittal, with congenital heart disease, mental deficiency, and mandibular ankylosis
|
[NCBI]
|
9.57611e-05
|
|
|
EIG
|
[NCBI]
|
8.85437e-05
|
|
|
RTS
|
[NCBI]
|
8.67743e-05
|
|
|
androstenone, ability to smell
|
[NCBI]
|
8.53201e-05
|
|
|
aprosencephaly syndrome
|
[NCBI]
|
8.53201e-05
|
|
|
hydroxyprolinemia
|
[NCBI]
|
7.85544e-05
|
|
|
fecundity gene, booroola, of sheep, homolog of
|
[NCBI]
|
7.85544e-05
|
|
|
EEG
|
[NCBI]
|
7.85544e-05
|
|
|
hair whorl
|
[NCBI]
|
7.85544e-05
|
|
|
atrioventricular conduction time
|
[NCBI]
|
7.85544e-05
|
|
|
respiratory underresponsiveness to hypoxia and hypercapnia
|
[NCBI]
|
7.85544e-05
|
|
|
hand clasping pattern
|
[NCBI]
|
7.85544e-05
|
|
|
tongue curling, folding, or rolling
|
[NCBI]
|
7.85544e-05
|
|
|
oculocerebrocutaneous syndrome
|
[NCBI]
|
7.35343e-05
|
|
|
lichen planus, familial
|
[NCBI]
|
7.35343e-05
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
7.35343e-05
|
|
|
MDD
|
[NCBI]
|
7.28183e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
6.95422e-05
|
|
|
whistling face syndrome, recessive form
|
[NCBI]
|
6.95422e-05
|
|
|
EHBA
|
[NCBI]
|
6.95422e-05
|
|
|
HPE4
|
[NCBI]
|
6.95422e-05
|
|
|
creatine phosphokinase, elevated serum
|
[NCBI]
|
6.95422e-05
|
|
|
EPHX2
|
[NCBI]
|
6.47747e-05
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
6.33997e-05
|
|
|
IDD
|
[NCBI]
|
6.33997e-05
|
|
|
SLE
|
[NCBI]
|
6.14927e-05
|
|
|
OCA3
|
[NCBI]
|
6.09309e-05
|
|
|
EDM4
|
[NCBI]
|
6.09309e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
6.09309e-05
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
5.87423e-05
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
5.87423e-05
|
|
|
SLC26A2
|
[NCBI]
|
5.79263e-05
|
|
|
DA2B
|
[NCBI]
|
5.49957e-05
|
|
|
HPE2
|
[NCBI]
|
5.49957e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
5.33776e-05
|
|
|
SHEP1
|
[NCBI]
|
5.33663e-05
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
5.33663e-05
|
|
|
HSR
|
[NCBI]
|
5.31141e-05
|
|
|
SCZD9
|
[NCBI]
|
5.18657e-05
|
|
|
COFS1
|
[NCBI]
|
5.18657e-05
|
|
|
CYP1A1
|
[NCBI]
|
5.07606e-05
|
|
|
UMS
|
[NCBI]
|
5.04755e-05
|
|
|
aging
|
[NCBI]
|
5.04755e-05
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
5.04755e-05
|
|
|
HPE3
|
[NCBI]
|
5.04755e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
4.91809e-05
|
|
|
longevity
|
[NCBI]
|
4.797e-05
|
|
|
BFLS
|
[NCBI]
|
4.57613e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
4.47485e-05
|
|
|
APL
|
[NCBI]
|
4.37884e-05
|
|
|
PI
|
[NCBI]
|
4.29669e-05
|
|
|
CHNG2
|
[NCBI]
|
4.20072e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
4.20072e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
4.20072e-05
|
|
|
sudden infant death syndrome
|
[NCBI]
|
4.20072e-05
|
|
|
osteoarthritis
|
[NCBI]
|
3.96254e-05
|
|
|
lung cancer
|
[NCBI]
|
3.96254e-05
|
|
|
CF
|
[NCBI]
|
3.82825e-05
|
|
|
SPDA1
|
[NCBI]
|
3.81966e-05
|
|
|
HSAS
|
[NCBI]
|
3.81966e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
3.7523e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
3.68741e-05
|
|
|
MYOZ2
|
[NCBI]
|
3.58735e-05
|
|
|
SGBS1
|
[NCBI]
|
3.56439e-05
|
|
|
TSNAX
|
[NCBI]
|
3.3854e-05
|
|
|
GCPS
|
[NCBI]
|
3.3417e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
3.3417e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
3.29024e-05
|
|
|
GDF9
|
[NCBI]
|
3.23529e-05
|
|
|
GLS
|
[NCBI]
|
3.23529e-05
|
|
|
POAG
|
[NCBI]
|
3.14461e-05
|
|
|
FOP
|
[NCBI]
|
3.14461e-05
|
|
|
PLA2G1B
|
[NCBI]
|
3.1157e-05
|
|
|
P2RX4
|
[NCBI]
|
3.1157e-05
|
|
|
IGER
|
[NCBI]
|
3.09872e-05
|
|
|
VDR
|
[NCBI]
|
2.95834e-05
|
|
|
obesity
|
[NCBI]
|
2.77123e-05
|
|
|
SULT1A1
|
[NCBI]
|
2.62808e-05
|
|
|
SFTPD
|
[NCBI]
|
2.62808e-05
|
|
|
FSHB
|
[NCBI]
|
2.54016e-05
|
|
|
MKS1
|
[NCBI]
|
2.499e-05
|
|
|
CYP1A2
|
[NCBI]
|
2.46368e-05
|
|
|
CES
|
[NCBI]
|
2.40798e-05
|
|
|
SHBG
|
[NCBI]
|
2.3657e-05
|
|
|
TD1
|
[NCBI]
|
2.35016e-05
|
|
|
CHH
|
[NCBI]
|
2.35016e-05
|
|
|
ERCC6
|
[NCBI]
|
2.33536e-05
|
|
|
SLC25A20
|
[NCBI]
|
2.23014e-05
|
|
|
ALDH1A1
|
[NCBI]
|
2.16204e-05
|
|
|
DISC1
|
[NCBI]
|
2.10106e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
2.0637e-05
|
|
|
ALPL
|
[NCBI]
|
2.0637e-05
|
|
|
PTPN11
|
[NCBI]
|
2.0637e-05
|
|
|
MTTK
|
[NCBI]
|
2.0118e-05
|
|
|
TYRP1
|
[NCBI]
|
1.99548e-05
|
|
|
NDP
|
[NCBI]
|
1.97961e-05
|
|
|
NS1
|
[NCBI]
|
1.97603e-05
|
|
|
ALDH2
|
[NCBI]
|
1.96416e-05
|
|
|
JAG1
|
[NCBI]
|
1.94912e-05
|
|
|
ABO
|
[NCBI]
|
1.94912e-05
|
|
|
ADIPOQ
|
[NCBI]
|
1.87926e-05
|
|
|
FLNA
|
[NCBI]
|
1.76076e-05
|
|
|
AD
|
[NCBI]
|
1.75896e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
1.67173e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.64484e-05
|
|
|
TGFB1
|
[NCBI]
|
1.63623e-05
|
|
|
TSC2
|
[NCBI]
|
1.58683e-05
|
|
|
SCZD
|
[NCBI]
|
1.5304e-05
|
|
|
HRG
|
[NCBI]
|
1.52001e-05
|
|
|
MTHFR
|
[NCBI]
|
1.50618e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
1.45405e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
1.45405e-05
|
|
|
MPZ
|
[NCBI]
|
1.43569e-05
|
|
|
GH1
|
[NCBI]
|
1.39509e-05
|
|
|
SRY
|
[NCBI]
|
1.38401e-05
|
|
|
ACH
|
[NCBI]
|
1.38247e-05
|
|
|
MC1R
|
[NCBI]
|
1.36251e-05
|
|
|
BBS
|
[NCBI]
|
1.30181e-05
|
|
|
PKD1
|
[NCBI]
|
1.28864e-05
|
|
|
GJB1
|
[NCBI]
|
1.28864e-05
|
|
|
PCD
|
[NCBI]
|
1.23868e-05
|
|
|
LPL
|
[NCBI]
|
1.21628e-05
|
|
|
APOB
|
[NCBI]
|
1.17827e-05
|
|
|
LEP
|
[NCBI]
|
1.14054e-05
|
|
|
CASR
|
[NCBI]
|
1.1336e-05
|
|
|
COMP
|
[NCBI]
|
9.84556e-06
|
|
|
MG
|
[NCBI]
|
8.65564e-06
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
8.53603e-06
|
|
|
FMF
|
[NCBI]
|
8.38647e-06
|
|
|
WBS
|
[NCBI]
|
8.28915e-06
|
|
|
MBL2
|
[NCBI]
|
7.4041e-06
|
|
|
INS
|
[NCBI]
|
7.38845e-06
|
|
|
VEGF
|
[NCBI]
|
6.79482e-06
|
|
|
ACE
|
[NCBI]
|
5.61998e-06
|
|
|
AFP
|
[NCBI]
|
3.71888e-06
|
|
|
WAS
|
[NCBI]
|
2.69957e-06
|
|
|
BWS
|
[NCBI]
|
2.54099e-06
|
|
|
GTS
|
[NCBI]
|
1.53917e-06
|
|
|
G6PD
|
[NCBI]
|
1.49297e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
1.32852e-06
|
|
|
ALD
|
[NCBI]
|
1.19272e-06
|
|
|
PD
|
[NCBI]
|
8.8748e-07
|
|
|
RP
|
[NCBI]
|
8.33089e-07
|
|
|
NPY
|
[NCBI]
|
6.3339e-07
|
|
|
CFTR
|
[NCBI]
|
3.77719e-07
|
|
|
FA
|
[NCBI]
|
3.19354e-07
|
|
|
PTH
|
[NCBI]
|
2.05118e-07
|
|
|
ACHE
|
[NCBI]
|
1.86987e-07
|
|
|
TH
|
[NCBI]
|
1.517e-07
|
|
|
TS
|
[NCBI]
|
1.46289e-07
|
|
|
PRL
|
[NCBI]
|
9.33713e-08
|
|
|
APOE
|
[NCBI]
|
7.57413e-08
|
|
|
EPO
|
[NCBI]
|
3.08642e-08
|
|
|
CEACAM5
|
[NCBI]
|
2.4167e-09
|
|
|
FTD
|
[NCBI]
|
1.74349e-09
|
|
|
BDNF
|
[NCBI]
|
1.36242e-09
|
|
|
IS1
|
[NCBI]
|
4.4402e-10
|
|